A previously healthy middle-aged woman noted a rapid onset of flank pain with gross hematuria. Enhanced CT scan showed thrombosis of the inferior vena cava and right renal vein. Laboratory findings revealed nephrotic proteinuria, Sjogren's syndrome (SjS), and Graves' disease (GD). A right nephrectomy was performed because of progressive and refractory renal necrosis. Renal specimens showed venous infarction with diffuse hemorrhagic and severe congestive renal necrosis, and membranous nephropathy (MN). The present case was diagnosed as acute renal necrosis due to catastrophic thrombosis in a patient with SjS, GD, and MN. It was thought that sudden development of thrombosis may have been caused by the status of the autoimmune disorders, and the associated MN.
Introduction
Spontaneous renal vein thrombosis (RVT) is rare in ambulatory subjects who do not have nephrotic syndrome (NS) with hypercoagulability, while it is a most common presentation in acquired venous thrombosis is deep vein thrombosis (1) . RVT is more often chronic and produces no symptoms referable to the kidney. Some cases due to trauma, severe dehydration or a generalized hypercoagulable state present acute RVT. Here, we present a case of renal congestive and hemorrhagic necrosis due to fulminant RVT spreading in intrarenal veins, and thrombosis of the inferior vena cava. Because this patient suffered from Sjogren's syndrome (SjS), Graves' disease (GD), and membranous nephropathy (MN), it is interesting to consider that the occurrence of the thrombosis might have been preceded by MN with nephrotic range proteinuria and autoimmune disorder milieu.
Case Report
A previously healthy woman in her forties noted a lowgrade fever and alopecia in mid June 2005. In early October 2005, she realized fatigue and hyperthermia. After a week with symptoms, she had exacerbated right flank pain with gross hematuria. She presented excess sweating, sinus tachycardia (120/minute), anterior neck swelling and pretibial edema. Her urinalysis showed nephrotic proteinuria, (5.5 g/ day) and hematuria (RBC>100/HPF). Laboratory tests showed decreased platelets and coagulation system abnormality (Table 1) . Serological tests were positive for antinuclear antibody (Ab) and both anti-SSA Ab and SSB-Ab, but negative for anti-dsDNA Ab and anti-Sm Ab. Neither cardiolipin IgG, IgA nor IgM Ab were detected. Lupus anticoagulant, anti-β2GP I Ab and anti-prothrombin Ab were negative ( Table 1 ). The thyroid stimulating hormone was less than detection level, while both FT3 and FT4 levels were increased. The thyroid receptor Ab was positive (Table 1) .
T a b l e 1 . L a b o r a t o r y F i n d i n g s o n Ad mi s s i o n F i g u r e 1 . F i n d i n g s o f e n h a n c e d CT s h o we d a n a b s e n c e o f b l o o d f l o w i n t h e r i g h t k i d n e y a n d t h r o mb o s i s o f t h e r i g h t r e n a l v e i n ( a r r o wh e a d ) a n d i n f e r i o r v e n a c a v a ( a r r o w) .
An enhanced CT scan and Doppler ultrasonography revealed an enlarged right kidney with an absence of blood flow and the continuous thrombosis from total right renal vein to the inferior vena cava (Fig. 1 ). Increased thyroidal 99 Tc uptake was detected. Salivary scintigraphy showed delayed uptake and reduced concentration in the parotid glands. A Rose Bengal staining test was negative, however, a gum test was positive (8 mL/10 minutes). A lip biopsy showed local periductal lymphoid cell infiltration (less than 1 focus/4 mm 2 ).
We diagnosed acute RVT with SjS and GD based on the symptoms and the examination findings. While her SjS was thought to be stage I, except for the renal disease, it was strongly suspected that she was suffering from GD-induced thyrotoxicosis by her clinical symptoms. Anticoagulation with heparin for the RVT and potassium iodide (50 mg/day) for hyperthyroidism were started, and methimazore (30 mg/ day) was administered after the diagnosis of GD was established ( Fig. 2) . Additionally, steroid (methylprednisolone 1,000 mg) and substitution therapy such as anti-thrombin (AT) III was administered (Fig. 2) . These therapies induced a generalized fibrinolytic state and fibrinogen tended to decrease. However, blood flow of the right kidney was not improved and thrombocytopenia was prolonged progressively. Her medical condition was markedly deteriorated with continued hyperthermia and severe right lateroabdominal pain. Therefore, a right nephrectomy was performed on day six of hospitalization (Fig. 2) .
The isolated kidney was swollen (145×85 mm; Fig. 3 ). Renal specimens showed diffuse thrombosis that was observed from the right renal vein to interlobular veins, and diffuse hemorrhagic cortical and medullar necrosis with severe congestion (Fig. 4A ). Arterial occlusion with infarction was not observed. Those findings suggested that diffuse thrombosis yielded impairment of venous outflow, and lead to severe congestion that produced diffuse hemorrhagic cortical and medullar necrosis. Glomerular capillary walls (GCW) of the surviving glomeruli were thick and fuchsinophilic deposits were observed along GCW (Fig. 4B ). While immunofluorescence examination could not be performed, IgG and C1q depositions around GCW were evaluated via immunohistochemistory method (Fig. 4C, D) . By electron microscope dense deposits were observed epithelial paramesangium and glomerular basement membrane ( Fig. 5 ). We defined the renal disease as MN stage I-II.
After the nephrectomy, the platelet count and fibrinogen level tended to improve and CRP level decreased (Fig. 2) . Anticoagulation therapy was changed from heparin to walfarin, while treatment for hyperthyroidism continued. Whereas FT3 and FT4 levels were normalized by treatment 
F i g u r e 3 . Co n g e s t e d a n d h e mo r r h a g i c s u r f a c e o f t h e r i g h t k i d n e y .
for hyperthyroidism, hyperthermia and nephrotic proteinuria prolonged (Fig. 2) . Prednisolone (40 mg/day) was administered, since a steroid therapy was essential for hyperthermia which was thought to be an SjS-associated symptom and for MN with nephrotic proteinuria. The therapy was effective for hyperthermia and proteinuria which decreased to approximately 2 g/day from nephrotic range within a month (Fig. 2 ).
Discussion
The present case is the acute RVT in an MN patient with SjS and GD-induced thyrotoxicosis. To the best of our knowledge, the present case is the first report in the English language literature in which renal necrosis developed due to rapid onset of RVT in a patient with an autoimmune disorder and membranous nephropathy, which finally required nephrectomy. (3) . Second, hyperthyroidism may display a tendency to develop thromboembolic complications through potential thrombosis mechanisms such as elevated hepatic protein synthesis e.g., fibrinogen (4, 5) and enhanced thrombin (5) 
It is of interest in RVT, that chronic RVT appears to be most common in conditions associated with nephrotic state, especially with MN in contrast to minimal change disease, focal glomerulosclerosis, and diabetic nephropathy (2). However, "acute" RVT is still an uncommon complication of MN, plus it very rarely leads to aggressive intrarenal veins thrombosis (IRVT) from RVT in adults (3). Therefore, it was speculated that an additional condition(s) due to thyrotoxicosis might enhance the hypercoagulability state. First, dehydration by excess sweating as GD-related thyrotoxicosis might possibly be associated with the hypercoagulability state, because IRVT is seen in some infancy cases complicated with severe dehydration by diarrheal diseases

. The pathogenesis of hypercoagulability of NS is multifaceted; many procoagulant factors such as fibrinogen are increased while anticoagulant and fibrinolysis factors, plasminogen and AT III, are lost into urine. The coagulation abnormality in NS is in part common to hyperthyroidism, thus there is a possibility that the GD-related thyrotoxicosis in the present case amplified the NS-related coagulation abnormalities.
Systemic autoimmune diseases such as SLE and antiphospholipid syndrome (APS) are frequently complicated with thrombosis and APS rarely leads to cortical necrosis (6) . The present case did not satisfy the diagnostic criteria of SLE and APS, on the other hand, she displayed complications with SjS. SjS sometimes contributes to the thrombogenic state by complication with vasculitis and phlebitis and occasionally SjS complicates thrombotic microangiopathy (TMA) (7) . In the present case there were no aggressive findings suggestive of TMA-like fragmented red blood cells, 7 0 0 0 ) . however, the high fever still continued after the nephrectomy in which period levels of thyroid hormone and abnormality of coagulation system tended to improve. Moreover, steroid therapy was effective for the hyperthermia (Fig. 2) . Following the clinical course it could not be denied that there was a synergistic effort of direct vessel injury by SjS-associated vein inflammation.
F i g u r e 4 . Co n g e s t i v e n e c r o s i s o f a l l c e l l u l a r e l e me n t s a n d h e mo r r h a g i c i n f a r c t wi t h s e v e r e c o n g e s t i v e mi c r o v e s s e l s ( F i g . 4 A × 2 0 0 ) . I n t h e s u r v i v i n g g l o me r u l i , t h e g l o me r u l a r c a p i l l a r y wa l l s ( GCW) we r e t h i c k a n d f u c h s i n o p h i l i c d e p o s i t s we r e o b s e r v e d a l o n g GCW ( F i g . 4 B Ma s s o n s t a i n × 4 0 0 ) . I g G ( F i g . 4 C × 1 0 0 ) a n d C1 q ( F i g . 4 D × 1 0 0 ) d e p o s i t i o n s a r o u n d GCW we r e r e v e a l e d b y i mmu n o h i s t o c h e mi s t r y .
F i g u r e 5 . De n s e d e p o s i t s i n t h e e p i t h e l i a l g l o me r u l a r b a s e me n t me mb r a n e we r e o b s e r v e d b y e l e c t r o n mi c r o s c o p e ( ×
In the present case, MN was considered "secondary" because of the distribution of dense deposits and the C1q staining around GCW. Regarding the association(s) of SjS and MN, or GD and MN, there are a few studies. The mechanisms are explained by the fact that cryogulobulinemia in SjS patients sometimes leads to MN as IC-initiated renal involvement (8) and GD may potentially be initiated by secondary MN mediated by IC including Tg and another antigen from the thyroid (9) . Unfortunately, in the present case, we could not show the reason(s) or mechanism(s) regarding SjS and/or GD-induced MN.
Usually, the main therapy for venous thrombosis is anticoagulation therapy, and coagulation disorder in patients with GD-related thyrotoxicosis requires normalization of thyroid hormone (9) . In the present case, RVT and IRVT were not improved by anticoagulation therapy with heparin, and potassium iodide and methimazole for the hypercoagulation state, while coagulation and fibrinolytic systems were effectively treated with those therapies. Whereas the treatment was possibly not sufficient to alleviate the thrombosis, it was speculated that other factors might be associated with thrombus formation. Other reason(s) of prolonged hypercoagulability might include insufficient treatment for MN with nephrotic state and SjS-associated vasculitis and phlebitis as mentioned above. After the diagnosis of MN was established, adequate steroid therapy was initiated which diminished the proteinuria and was effective for hyperthermia ( Fig. 2 ). There are a few affirmative writings on steroid therapy in both SjS-and GD-associated MN (8, 9) . Because the beneficial effects of steroids are not only for MN but also for thyrotoxicosis and hypercoagulability and venous inflammation with SjS (10) , it should be considered that immunosuppressive therapy including steroids is attempted against the thrombogenic tendency in those patients.
In conclusion, it is best to consider NS patients at risk of developing venous thrombosis when they suffer SjS and/or GD especially with thyrotoxicosis. Thereby it may confer that nephritic state-related thrombogenecity is enhanced by SjS and GD concomitant with thyrotoxicosis representing a coagulation disturbance.
